Compare Punarnavadighan vati with Punarnavadi chooran in Sciatica (Gridhrasi)

A comparative Pharmaceutico-analytical study of Punarnavadi chooran and Punarnavadi ghan vati and their clinical efficacy in Gridhrasi WSR to Sciatica

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035473

Enrollment

Registered

2021-08-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G570- Lesion of sciatic nerve

Interventions

Intervention1: Punarnavadi Choorna: Punarnavadi Choorna will be given to 15 patients twice daily 30 mins after meal for 30 days Control Intervention1: Punarnavadi Ghan Vati: 500 mg tablet of Punarnava

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing for trial. patients with sign and symptoms of Gridhrasi (Sciatica) described in classical Ayurvedic text and modern literature. patients with Sciatica nerve pain due to L4-L5 or L5-S1 disc prolapse.

Exclusion criteria

Exclusion criteria: patient below 20 years and above 70 years, anaemia pregnancy

Design outcomes

Primary

Measure	Time frame
To asscess the subjective symptoms like:- stambha (Stiffness) Toda (Pricking sensation) Spandana (Fasciculation) Aruchi Tandra gauravTimepoint: 1st day 10th day 20th day 30th day	—

Secondary

Measure	Time frame
to asscess the objective parameters like:- SLRTimepoint: 1 st day 10th day 20th day 30th day	—

Countries

India

Contacts

Public ContactDr Harvinder Grover

Post Graduate Training and research institute Government Ayurvedic College Patiala

drharvinder1959@gmail.com9814221927

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026